In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Pazopanib (LUCiPazo) is indicated for adult patients with advanced renal cell ca···【more】
Release date:2026-10-21Recommended:4
For adult patients with advanced gastrointestinal stromal tumors (GIST) who have···【more】
Release date:2026-10-21Recommended:3
Tenapanor (LuciTena) is indicated to reduce serum phosphorus levels in adult pat···【more】
Release date:2026-10-21Recommended:9
Nirogacestat (LuciNiro) is indicated for adult patients with progressing desmoid···【more】
Release date:2026-10-21Recommended:7
During treatment with LuciDarax(Daraxonrasib), please have blood counts and bioc···【more】
Release date:2026-10-14Recommended:202
Before using LuciDarax(Daraxonrasib), prophylactic skin care is required. Prepar···【more】
Release date:2026-10-14Recommended:214
For treatment of H3 K27M-mutant diffuse midline glioma progressing after prior t···【more】
Release date:2026-10-13Recommended:9
The recommended dose of LuciDarax(Daraxonrasib) is 300 mg, orally, once daily, u···【more】
Release date:2026-10-12Recommended:232
LuciDarax(Daraxonrasib) is an oral pan-RAS inhibitor for adults with metastatic ···【more】
Release date:2026-10-12Recommended:290
During treatment with LuciDarax(Daraxonrasib), please follow your doctor's i···【more】
Release date:2026-10-10Recommended:501
LuciDarax(Daraxonrasib) was approved by the U.S. FDA on August 26, 2026, under t···【more】
Release date:2026-10-10Recommended:551
Daraxonrasib for adults with metastatic pancreatic adenocarcinoma who have had ≥···【more】
Release date:2026-10-10Recommended:139